Leaflet: information for the user
Dicorynan 100 mg hard capsules
disopyramide
Read this leaflet carefully before you start to take this medicine, because it contains important information for you.
6. Contents of the pack and additional information
Dicorynan belongs to a group of medications called class IA antiarrhythmics.
Dicorynan is indicated for the treatment or prevention of cardiac rhythm disturbances such as:
premature contractions originating above the ventricle (supraventricular extrasystoles).
Do not take Dicorynan:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Dicorynan.
-if you have or have had heart problems: cardiomyopathies, structural heart disease, proarrhythmia, or heart failure,
Administration of disopyramide should be avoided in patients with glaucoma. In patients with glaucoma or a family history of glaucoma, intraocular pressure should be measured before starting treatment.
Especially, inform your doctor if you are taking:
Pregnancy and breastfeeding
It is not recommended to take Dicorynan during pregnancy, unless your doctor considers that the benefits outweigh the risks.
Disopyramide passes into breast milk, so this medication should not be taken during the breastfeeding period.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medication.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Remember to take your medication.
Dicorynan is administered orally.
The recommended dose is:
Treatment should begin with 100 mg (1 capsule) every 6 hours, increasing or decreasing this dose according to the patient's response.
The usual maintenance dose is typically 300 mg or 400 mg per day, distributed throughout the day in 3 or 4 doses (1 capsule every 3 or 4 hours).
Your doctor will indicate your daily dose and the duration of your treatment. Do not discontinue treatment without consulting your doctor first.
If it is necessary to administer higher doses, measures will be taken to ensure proper monitoring and control of the patient.
In patients with altered liver and/or renal functioncardiac function will be monitored using an electrocardiogram to adjust the dose.
If you estimate that Dicorynan's action is too strong or too weak, inform your doctor or pharmacist.
If you take more Dicorynan than you should
The most common symptoms in cases of overdose are: paralytic ileus (intestinal blockage due to paralysis of intestinal muscles), hypotension (low blood pressure), heart failure, arrhythmias, respiratory disturbances, and coma.
In the event of ingesting a large amount of medication, either accidentally or intentionally, the patient should be immediately hospitalized and subjected to continuous monitoring of cardiac function.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount taken. It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
If you forgot to take Dicorynan
Do not take a double dose to compensate for the missed doses.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The most common side effects are due to its anticholinergic activity (activity on the nervous system) and depend on the dose. Among these effects, urinary retention is the most serious.
Inform your doctor immediately if you notice any of the following serious side effects; you may need urgent medical treatment:
These are very rare(they can affect up to 1 in 10,000 patients)
The following cardiac effects may occur, although they are not the most common. The frequency is unknown(the frequency cannot be estimated from the available data)
Other side effects
Inform your doctor as soon as possible if you have any of the following side effects:
Rare(they can affect up to 1 in 1,000 patients)
Very rare(they can affect up to 1 in 10,000 patients)
Unknown frequency(the frequency cannot be estimated from the available data)
Inform your doctor or pharmacist if any of the following side effects worsen or last more than a few days, or if you notice any side effect not mentioned in this leaflet:
Common(they can affect up to 1 in 10 patients)
Uncommon(they can affect up to 1 in 100 patients)
Rare(they can affect up to 1 in 1,000 patients)
Very rare(they can affect up to 1 in 10,000 patients)
Unknown frequency(the frequency cannot be estimated from the available data)
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not mentioned in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: htpps://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Composition of Dicorynan
- The active ingredient is disopyramide. Each capsule contains 100 mg of disopyramide.
- The other components (excipients) are: lactose, cornstarch, magnesium stearate, and talc.
Appearance of the product and content of the packaging
Dicorynan 100 mg is presented in the form of hard capsules for oral administration. They are green and yellow capsules.
Dicorynan 100 mg is presented in packaging of 40 hard capsules.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
CHEPLAPHARM Arzneimittel GmbH
Ziegelhof 24
17489 Greifswald
Germany
Local Representative
Laboratorios Rubió, S.A.
Industria, 29
Pol. Ind. Comte de Sert
08755 Castellbisbal (Barcelona)
Spain
Responsible for manufacturing:
Opella Healthcare International SAS
56, Route de Choisy
60200 Compiègne (France)
Other sources of information
The detailed information of this medication is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/ )
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.